Fixed low-dose combination in first-line treatment of hypertension

Journal of Hypertension

Volumn 20, Issue SUPL. 1, 2002, Pages

  Prisant, L Michael ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Black; Combination drug therapy; Elderly; Hypertension; Treatment

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; BISOPROLOL; BUCINDOLOL; CALCIUM ANTAGONIST; CARVEDILOL; DILTIAZEM; DOXAZOSIN; ENALAPRIL; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL; PLACEBO; PRAZOSIN; PROPRANOLOL; TERAZOSIN; VERAPAMIL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG COST; DRUG SCREENING; EDEMA; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; META ANALYSIS; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0036464251     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (51)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
2. Low-dose combination therapy in hypertension
3. Hypertension: The rediscovery of combination therapy
4. Meet the experts: Effective use of combination drug therapy in the treatment of minority hypertensive populations. Combination therapy: Rediscovered
5. Remembering the lessons of basic pharmacology
6. Treating the individual patient: Considerations on dose, sequential monotherapy and drug combinations
7. Fixed-dose combination medications for the treatment of hypertension: A critical review
8. The place of combination therapy in the treatment of hypertension in 1993
9. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy
10. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
11. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
12. Effect of carvedilol on survival in severe chronic heart failure
13. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment
14. Guidelines subcommittee
15. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis
16. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension
17. Effects of diuretic therapy and exercise-related arrhythmias in systemic hypertension
18. Effect of diuretics on cardiac arrhythmias and left ventricular hypertrophy in hypertension
19. Diuretics and β-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension
20. Diuretics and β-blockers: Is there a risk for dyslipidemia?
21. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
22. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
23. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
24. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery
25. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
26. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
27. Use of β-adrenergic receptor blockers in blacks
28. Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks
29. Sexual dysfunction with antihypertensive drugs
30. Combination products as first-line pharmacotherapy
31. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide
32. β-adrenergic receptor blockade in chronic heart failure
33. Multicenter evaluation of the hemodynamic effects of bisoprolol in patients with mild to moderate hypertension
34. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension
35. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension
36. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
37. Bisoprolol fumarate/hydrochlorothiazide 6.25 mg: A new low-dose option for first-line antihypertensive therapy
38. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program
39. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: The efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo
40. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
41. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components
42. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
43. Comparison of bisoprolol and low dose hydrochlorothiazide combination with losartan, alone or in combination with hydrochlorothiazide, in the treatment of hypertension: A double blind randomized controlled trial
44. A first-line treatment option for elderly hypertensive patients: A low-dose multimechanism β-blocker/diuretic
45. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension
46. Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension
47. A new antihypertensive strategy for black patients: Low-dose multimechanism therapy
48. Hypertension in the elderly: Can we improve results of therapy?
49. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy
50. Self reported sexual dysfunction in men and women treated with bisoprolol, hydrochlorothiazide, enalapril, amlodipine, placebo or bisoprolol/hydrochlorothiazide
51. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: Combined analysis of comparative studies